Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia

Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia

Junji Saruwatari,1,* Norio Yasui-Furukori,2,* Ryoko Kamihashi,1 Yuki Yoshimori,1 Kentaro Oniki,1 Shoko Tsuchimine,2 Madoka Noai,1 Yasushi Sato,3 Taku Nakagami,4 Norio Sugawara,2 Manabu Saito,2 Akira Fujii,2 Ayami Kajiwara,1 Shuichi Mihara,5 Yasuhiro Ogata,6 Sunao Kaneko,2 Kazuko Nakagawa1,71Division...

Full description

Bibliographic Details
Main Authors:	Saruwatari J, Yasui-Furukori N, Kamihashi R, Yoshimori Y, Oniki K, Tsuchimine S, Noai M, Sato Y, Nakagami T, Sugawara N, Saito M, Fujii A, Kajiwara A, Mihara S, Ogata Y, Kaneko S, Nakagawa K
Format:	Article
Language:	English
Published:	Dove Medical Press 2013-11-01
Series:	Neuropsychiatric Disease and Treatment
Online Access:	http://www.dovepress.com/possible-associations-between-antioxidant-enzyme-polymorphisms-and-met-a14872

Similar Items

Possible association between moderate intellectual disability and weight gain in valproic acid–treated patients with epilepsy
by: Tanamachi Y, et al.
Published: (2015-04-01)

Dietary patterns and schizophrenia: a comparison with healthy controls
by: Tsuruga K, et al.
Published: (2015-04-01)

Body composition in patients with schizophrenia: Comparison with healthy controls
by: Sugawara Norio, et al.
Published: (2012-05-01)

Effect of age and disease on bone mass in Japanese patients with schizophrenia
by: Sugawara Norio, et al.
Published: (2012-02-01)

Attitudes toward Placebo-Controlled Clinical Trials of Patients with Schizophrenia in Japan.
by: Norio Sugawara, et al.
Published: (2015-01-01)

Work–family conflict as a mediator between occupational stress and psychological health among mental health nurses in Japan
by: Sugawara N, et al.
Published: (2017-03-01)

Differential effects of the catechol-O-methyltransferase Val158Met genotype on the cognitive function of schizophrenia patients and healthy Japanese individuals.
by: Shoko Tsuchimine, et al.
Published: (2013-01-01)

Effects of Antipsychotics on Arrhythmogenic Parameters in Schizophrenia Patients: Beyond Corrected QT Interval
by: Okayasu H, et al.
Published: (2021-01-01)

ABO Blood Type and Personality Traits in Healthy Japanese Subjects.
by: Shoko Tsuchimine, et al.
Published: (2015-01-01)

Differences in etiological beliefs about schizophrenia among patients, family, and medical staff
by: Tarakita N, et al.
Published: (2018-12-01)

Impact of the superoxide dismutase 2 Val16Ala polymorphism on the relationship between valproic acid exposure and elevation of γ-glutamyltransferase in patients with epilepsy: a population pharmacokinetic-pharmacodynamic analysis.
by: Naoki Ogusu, et al.
Published: (2014-01-01)

Possible impact of the CYP2D6*10 polymorphism on the nonlinear pharmacokinetic parameter estimates of paroxetine in Japanese patients with major depressive disorders
by: Saruwatari J, et al.
Published: (2014-04-01)

Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment
by: Kawamata Y, et al.
Published: (2021-06-01)

The low level of understanding of depression among patients treated with antidepressants: a survey of 424 outpatients in Japan
by: Kudo S, et al.
Published: (2015-10-01)

Prescribing Trends for the Same Patients with Schizophrenia Over 20 Years
by: Yasui-Furukori N, et al.
Published: (2023-04-01)

Relationship Between Cognitive Functions and Decision-Making Capacity in Older Institutionalized Patients with Schizophrenia: A Preliminary Study
by: Sugawara N, et al.
Published: (2022-04-01)

Survey of Health Literacy Among Japanese Outpatients with Mental Illness
by: Sato Y, et al.
Published: (2023-06-01)

Sex differences in the prediction of the effectiveness of paroxetine for patients with major depressive disorder identified using a receiver operating characteristic curve analysis for early response [Corrigendum]
by: Tomita T, et al.
Published: (2014-06-01)

Competence to Consent and Its Relationship With Cognitive Function in Patients With Schizophrenia
by: Norio Sugawara, et al.
Published: (2019-04-01)

Update on the development of lurasidone as a treatment for patients with acute schizophrenia
by: Yasui-Furukori N
Published: (2012-05-01)

Predictive Utility of Body Mass Index for Metabolic Syndrome Among Patients with Schizophrenia in Japan
by: Sugawara N, et al.
Published: (2020-09-01)

Sex Differences In Psychoeducation For Patients With Depression: A Comparison Of Frequency And Efficacy Of Psychoeducation
by: Tomita T, et al.
Published: (2019-11-01)

The characteristics of understanding of depression among older patients treated with antidepressants: a comparison between older and younger patients
by: Tomita T, et al.
Published: (2018-05-01)

The associations of the number of medications and the use of anticholinergics with recovery from tubal feeding: a longitudinal hospital-based study
by: Keiji Takata, et al.
Published: (2020-09-01)

Serotonin syndrome induced by the readministration of escitalopram after a short-term interruption in an elderly woman with depression: a case report
by: Sato Y, et al.
Published: (2015-09-01)

Differences in self‐reported psychotic symptoms between patients with autism spectrum disorder and those with schizophrenia
by: Momoka Yamada, et al.
Published: (2023-09-01)

Relationship Between Diabetic Chorea and Timing of MRI Findings: A Systematic Review with Case Reports
by: Otaka Y, et al.
Published: (2023-10-01)

Comparing the influences of age and disease on the Brief Assessment of Cognition in Schizophrenia in Japanese patients with schizophrenia
by: Kaneda A, et al.
Published: (2013-08-01)

Recent trends in antipsychotic polypharmacy in the treatment of schizophrenia
by: Norio Yasui‐Furukori, et al.
Published: (2020-09-01)

No association between dietary patterns and depressive symptoms among a community-dwelling population in Japan
by: Sugawara Norio, et al.
Published: (2012-09-01)

Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder
by: Aoki A, et al.
Published: (2014-09-01)

A Pilot Study Assessing the Possible Combined Effect of Physical Activity and PNPLA3 rs738409 Polymorphism on the Risk for Non-Alcoholic Fatty Liver Disease in the Japanese Elderly General Population
by: Muto N, et al.
Published: (2020-02-01)

Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers
by: Ishioka M, et al.
Published: (2015-02-01)

Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels
by: Minami Tasaki, et al.
Published: (2021-09-01)

Worsened hypertension control induced by aripiprazole
by: Yasui-Furukori N, et al.
Published: (2013-04-01)

Determination of the Optimal Concentration of Valproic Acid in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis.
by: Hiroo Nakashima, et al.
Published: (2015-01-01)

The Relationship Between Baseline Clinical Symptom Characteristics and Working Ability in Japanese Patients Treated for Major Depressive Disorder and Painful Physical Symptoms
by: Sugawara N, et al.
Published: (2020-12-01)

Clozapine-induced seizures, electroencephalography abnormalities, and clinical responses in Japanese patients with schizophrenia
by: Kikuchi YS, et al.
Published: (2014-10-01)

Psychiatrists' attitudes toward metabolic adverse events in patients with schizophrenia.
by: Norio Sugawara, et al.
Published: (2014-01-01)

Delirium in hemodialysis predicts mortality: a single-center, long-term observational study
by: Yasui-Furukori N, et al.
Published: (2017-12-01)